---
title: "Seaport and Hemab target $180m IPOs as biotech listings accumulate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284375788.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-04-28T10:22:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284375788.md)
  - [en](https://longbridge.com/en/news/284375788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284375788.md)
generator: "portal-rs"
---

# Seaport and Hemab target $180m IPOs as biotech listings accumulate

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [426CVR015TMP.US](https://longbridge.com/en/quote/426CVR015TMP.US.md)
- [COEP.US](https://longbridge.com/en/quote/COEP.US.md)
- [NBSE.ESC.US](https://longbridge.com/en/quote/NBSE.ESC.US.md)
- [SEELQ.US](https://longbridge.com/en/quote/SEELQ.US.md)
- [SEEL.US](https://longbridge.com/en/quote/SEEL.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [SEG.US](https://longbridge.com/en/quote/SEG.US.md)

## Related News & Research

- [LIVE MARKETS-BofA clients flock to tech stocks](https://longbridge.com/en/news/296383193.md)
- [3 healthcare ETFs to own in a choppy stock market](https://longbridge.com/en/news/291834343.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**